Showing results (1871-1880 of 1,888) with videos related to

Sort By:
Pageof 189
Bioscience|December 10, 2025
Evolvability: progress and key questionsChristophe Pélabon, Gustavo A Agudelo-Cantero, Yimen G Araya Ajoy, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseasesMichel Gallant, Christian Beaulieu, Carl Berthelette, et al.
Journal of Medicinal Chemistry|April 4, 2018
Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking HypopigmentationBrian T O'Neill, Elizabeth M Beck, Christopher R Butler, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Parkinsonism & Related Disorders|December 6, 2020
Exome-wide rare variant analysis in familial essential tremorMonica Diez-Fairen, Gabrielle Houle, Sara Ortega-Cubero, et al.
JAMA Dermatology|January 18, 2023
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and EuropeMargo J Reeder, Erin Warshaw, Srikanth Aravamuthan, et al.
Nature Communications|July 23, 2021
An on-demand, drop-on-drop method for studying enzyme catalysis by serial crystallographyAgata Butryn, Philipp S Simon, Pierre Aller, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences|May 18, 2026
Evaluation of a PET Insert for Trimodal Imaging: A Step Toward PET/MRI-Guided Focused UltrasoundF Lopez-Berenguer, A Gonzalez-Montoro, M Freire, et al.
Journal of Medicinal Chemistry|August 18, 2017
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman PrimatesAntonia F Stepan, Michelle M Claffey, Matthew R Reese, et al.
Pageof 189